Physician profile
Natasha Rich
NPI 1215302559
$666.62
in general payments reported to CMS, 2019-2025
12 companies · $495 in 2025
The $495 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.68 · 2024: $160 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $98.74 | 2024-2025 | Nexplanon, Nuvaring |
| Exeltis, USA INC. | $92.21 | 2024-2025 | Slynd |
| Mayne Pharma Commercial LLC | $74.00 | 2024-2025 | |
| Millicent US INC | $62.57 | 2025 | Intrarosa, Femlyv, Femring |
| Biogen, INC. | $62.57 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $54.81 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Coopersurgical, INC. | $42.68 | 2024-2025 | Paragard T 380a |
| Hologic Sales and Service, LLC | $41.67 | 2024-2025 | Omni Hysteroscope, Myosure Tissue Removal Device, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $39.13 | 2025 | |
| Channel Medsystems, INC. | $38.73 | 2025 | |
| Merck Sharp & Dohme LLC | $36.50 | 2020-2024 | Gardasil 9, Gardasil |
| Pfizer INC. | $23.01 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natasha Rich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.